According to ResMed's latest financial reports the company has a price-to-book ratio of 6.61931.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 6.52 | 15.42% |
2023-12-31 | 5.65 | -30.78% |
2022-12-31 | 8.16 | -32.63% |
2021-12-31 | 12.1 | 12.6% |
2020-12-31 | 10.8 | 8.34% |
2019-12-31 | 9.92 | 18.97% |
2018-12-31 | 8.34 | 40.16% |
2017-12-31 | 5.95 | 16.35% |
2016-12-31 | 5.11 | 3.72% |
2015-12-31 | 4.93 | -0.47% |
2014-12-31 | 4.95 | 21.81% |
2013-12-31 | 4.07 | 19.52% |
2012-12-31 | 3.40 | 42.19% |
2011-12-31 | 2.39 | -27.48% |
2010-12-31 | 3.30 | 5.58% |
2009-12-31 | 3.13 | 6.18% |
2008-12-31 | 2.94 | -26.73% |
2007-12-31 | 4.02 | -9.44% |
2006-12-31 | 4.44 | -14.47% |
2005-12-31 | 5.19 | 27.14% |
2004-12-31 | 4.08 | -2.63% |
2003-12-31 | 4.19 | -9.15% |
2002-12-31 | 4.61 |